Jump to page content

In 2020, Charité - Universitätsmedizin Berlin and the Israel Innovation Authority jointly launched a program for innovation funding and validation in the field of digital medicine/medical technology, which is now entering its second round. Under the first IIA-Health Tech Pilot Program, four contracts have already been successfully signed in October 2021. This program had a pilot character at Charité and in the future will also serve as a blueprint for collaboration with other countries to bring international innovations to the Charité. 

 As a result of the good and successful collaboration of the first funding call, the so-called International Health-Tech R&D and Pilot Program has been re-opened on Sept. 19, 2022. Israeli startups can apply for financial support from the Israel Innovation Authority and get access to the resources or expertise of a selected clinical project partner. The goal is to establish collaborations between excellent clinicians and scientists from Charité/BIH and Israeli startups with great innovation potential. The funded projects can include R&D activities, clinical trials in all phases, pilot studies and validation studies. The goal here is clear: beeing successful in translational science and thereby improving patient care in Germany and beyond. 

 Israeli companies could apply with their projects until Nov. 14, 2022. In the second phase of the program (until June 2023), Charité/BIH researchers can now plan a collaborative project with a startup to jointly apply to the IIA for funding.

We are excited about collaborating with one of the world’s leading countries in terms of innovation and start-up culture.

Dr. Sein Schmidt, Head of the BIH Clinical Research Unit at the Charité and coordinator of the Israel-project

Background and Program

  • Background

    Israel Innovation Authority and the cooperation with the Charité and BIH.

    Read more
  • Program

    Information on the Program, conditions of participation, selection process and application deadlines.

    Read more

Startups and Agenda

Germany is Israel’s most important trading partner in the European Union.

H.E. Jeremy Issacharoff, Israel’s Ambassador in Germany

Project head

Dr. med. Sein Schmidt
Scientific and Medical Director, Clinical Trial Unit – Clinical Study Center (CSC), BIH, Charité

Partners

Contact persons

  • Dr. Verena Benz

    Head of Match & Connect –International Startup Partnerships (interim)

    Contact information
    Phone:+49 30 450 543 025
    E-mail:verena.benz@bih-charite.de
  • Dr. Hana Hastor

    Medical Advisor

    Clinical Study Center (CSC), Clinical Trial Unit (CTU)

    Contact information
    Phone:+49 30 450 643 687
    E-mail:hana.hastor@charite.de
  • Dr. med. Sein Schmidt

    Scientific and Medical Director of the Clinical Trial Unit of the Clinical Study Center (CSC), BIH, Charité

  • Dr. Maria Rönnefarth

    Projektkoordination der Kooperation in der Clinical Trial Unit des Clinical Study Center (CSC), BIH, Charité

    Contact information
    Phone:+49 30 450 643 653
    E-mail:maria.roennefarth@charite.de
  • Luise Roither

    Strategic Co-operations Manager/ Head of Match & Connect – International Startup Partnerships

    (parental leave)

    Contact information
    Phone:+49 30 450 543 025
    E-mail:luise.roither@bih-charite.de